|
ATPAF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.082600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.169600E-01 |
| Normal-vs-Stage2 |
1.827720E-02 |
| Normal-vs-Stage3 |
7.561500E-03 |
| Normal-vs-Stage4 |
4.144300E-02 |
| Stage1-vs-Stage2 |
2.700600E-03 |
| Stage1-vs-Stage3 |
4.763700E-02 |
| Stage1-vs-Stage4 |
1.523210E-01 |
| Stage2-vs-Stage3 |
2.017200E-04 |
| Stage2-vs-Stage4 |
6.383100E-04 |
| Stage3-vs-Stage4 |
9.537200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.943500E-02 |
| Normal-vs-AfricanAmerican |
7.134000E-01 |
| Normal-vs-Asian |
4.313000E-01 |
| Caucasian-vs-AfricanAmerican |
1.225970E-01 |
| Caucasian-vs-Asian |
7.021800E-01 |
| AfricanAmerican-vs-Asian |
4.057200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.586250E-01 |
| Normal-vs-Female |
3.064400E-01 |
| Male-vs-Female |
5.029400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.019200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.533590E-01 |
| Normal-vs-Age(61-80Yrs) |
5.360600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.098000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.117000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.709600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.751800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.138100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.660800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.402000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.475300E-03 |
| Classical-VS-Follicular |
3.29120000031047E-07 |
| Classical-VS-Other |
9.140000E-01 |
| Classical-VS-Normal |
6.070500E-02 |
| Tall-VS-Follicular |
9.33550015069784E-10 |
| Tall-VS-Other |
3.590400E-01 |
| Tall-VS-Normal |
1.350860E-04 |
| Follicular-VS-Other |
1.311420E-01 |
| Follicular-VS-Normal |
1.444430E-03 |
| Other-VS-Normal |
7.121200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.536800E-01 |
| Normal-vs-N1 |
3.045800E-04 |
| N0-vs-N1 |
1.203340E-04 |
|
|
